2014
DOI: 10.1016/s1590-8658(14)60302-9
|View full text |Cite
|
Sign up to set email alerts
|

P.13.5 Colorectal Cancer in Patients With Type 2 Diabetes Mellitus: Preliminary Results From an Ongoing Case-Control Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Similarly, several epidemiological studies reported a close association between IR assessed by the homeostasis model assessment method (HOMA-IR) and the risk of colorectal cancer ( 23 , 24 ), as did experimental studies ( 25 , 26 ). A study speculated sulphonylureas may play a role in CRC carcinogenesis impairing the physiological insulin secretion among diabetes participants ( 27 ).…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, several epidemiological studies reported a close association between IR assessed by the homeostasis model assessment method (HOMA-IR) and the risk of colorectal cancer ( 23 , 24 ), as did experimental studies ( 25 , 26 ). A study speculated sulphonylureas may play a role in CRC carcinogenesis impairing the physiological insulin secretion among diabetes participants ( 27 ).…”
Section: Discussionmentioning
confidence: 99%
“…These results were confirmed in a recently published cohort study by the same author on 169,601 patients using metformin (HR 0.50, 95 % confidence interval (CI): 0.45-0.56). Similarly, Sinagra et al have shown that longer duration of diabetes is associated with higher risk of CRC (p = 0.001) in the cohort of 741 Caucasian patients with type 2 diabetes [48]. In a large population-based study (36,270 patients with diabetes and 145,080 patients without diabetes), Lin et al showed an increased incidence of cancer, especially gastroenterological malignancies (except for esophageal cancer), in patients with diabetes.…”
Section: The Incidence Of Colorectal Cancermentioning
confidence: 89%
“…Four large cohort studies from the Taiwanese population have been published [47][48][49][50]. First, it was reported that patients with diabetes had a significantly higher risk (24 %) of CRC (relative risk (RR) 1.243, 95 % confidence interval (CI) 1.105-1.399, p = 0.0003) and metformin users had a significantly lower risk (RR 0.731, 95 % CI 0.580-0.921, p = 0.0078), particularly when the duration of exposure to metformin was longer than 3 years (RR 1.185, 95 % CI (1.055, 1.330), p = 0.0042).…”
Section: The Incidence Of Colorectal Cancermentioning
confidence: 99%